Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BBV 152

Next Previous
X
Search
Drug Profile

BBV 152

Alternative Names: BBV-152; BBV152D; Coronavirus vaccine-ICMR/BBIL; COVAXIN; COVID-2019 vaccine - Bharat Biotech International/Indian Council of Medical Research; Whole-Virion Inactivated SARS-CoV-2 Vaccine

Latest Information Update: 16 Jan 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bharat Biotech; The Indian Council of Medical Research
  • Developer Bharat Biotech; Ocugen; The Indian Council of Medical Research
  • Class COVID-19 vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered COVID 2019 infections

Most Recent Events

  • 09 Jan 2023 Efficacy and adverse events data from phase II/III trial in COVID-2019 infections were released by Ocugen
  • 22 Sep 2022 Ocugen completes an expanded-access programme for COVID-19 infection (In adults, In the elderly, Prevention) in US (NCT05541289)
  • 15 Sep 2022 Ocugen initiates an expanded-access programme for COVID-19 infection (In adults, In the elderly, Prevention) in US (NCT05541289)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top